Patents by Inventor Filip Janku

Filip Janku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION AND ANTI-TUMOR AGENT FOR TUMOR HAVING DECREASED FUNCTION OF AT LEAST ONE OF BAP1 OR PBRM1
    Publication number: 20240207301
    Abstract: An object of the present invention is to provide a pharmaceutical composition and an anti-tumor agent that exhibit an effect on a tumor having a decreased function of at least one of BAP1 or PBRM1. According to the present invention, there is provided a pharmaceutical composition for the treatment of a tumor having a decreased function of at least one of BAP1 or PBRM1, the pharmaceutical composition including 1-(2-deoxy-2-fluoro-4-thio-?-D-arabinofuranosyl)cytosine or a salt or prodrug thereof.
    Type: Application
    Filed: January 26, 2024
    Publication date: June 27, 2024
    Applicant: FUJIFILM Corporation
    Inventors: Kazunori SAEKI, David WAGES, Kin CHEUNG, Filip JANKU
  • Antitumor agent for biliary tract cancer and method for treating biliary tract cancer
    Patent number: 11141421
    Abstract: It is an object of the present invention to provide an antitumor agent for biliary tract cancer that exhibits effects on biliary tract cancer, and a method for treating biliary tract cancer. According to the present invention, provided is an antitumor agent for biliary tract cancer, comprising 1-(2-deoxy-2-fluoro-4-thio-?-D-arabinofuranosyl)cytosine, a salt thereof, or a prodrug thereof.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: October 12, 2021
    Assignee: FUJIFILM Corporation
    Inventor: Filip Janku
  • ANTITUMOR AGENT FOR BILIARY TRACT CANCER AND METHOD FOR TREATING BILIARY TRACT CANCER
    Publication number: 20200352973
    Abstract: It is an object of the present invention to provide an antitumor agent for biliary tract cancer that exhibits effects on biliary tract cancer, and a method for treating biliary tract cancer. According to the present invention, provided is an antitumor agent for biliary tract cancer, comprising 1-(2-deoxy-2-fluoro-4-thio-?-D-arabinofuranosyl)cytosine, a salt thereof, or a prodrug thereof.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Applicant: FUJIFILM Corporation
    Inventor: Filip JANKU
  • MONITORING TREATMENT OF HISTIOCYTOSIS WITH VEMURAFENIB AND DABRAFENIB
    Publication number: 20150344957
    Abstract: Provided are methods of determining the amount of a BRAF V600E mutation over time in a subject with Langerhans Cell Histiocytosis (LCH) or Erdheim-Chester Disease (ECD) who is being treated with vemurafenib or dabrafenib.
    Type: Application
    Filed: May 30, 2015
    Publication date: December 3, 2015
    Inventors: Omar Abdel-Wahab, Elie L. Diamond, David M. Hyman, Filip Janku, Mark G. Erlander, Cecile Rose T. Vibat
  • DETECTING AND MONITORING MUTATIONS IN HISTIOCYTOSIS
    Publication number: 20150132256
    Abstract: Provided is methods of detecting a mutation in a histiocytosis patient. Also provided is methods of selecting and/or applying treatment or therapy for a histiocytosis patient. Further provided is a method of treating a patient having a histiocytosis.
    Type: Application
    Filed: October 18, 2014
    Publication date: May 14, 2015
    Inventors: Filip Janku, Mark G. Erlander, Cecile Rose Vibat, Karena Kosco, Abdel-Wahab Omar, Eli L. Diamond, David M. Hyman